Persist AI
Persist accelerates long-acting drug development by 50% using AI.
Persist accelerates long-acting drug development by 50% using AI.
persist.aiCrawled Oct 16, 2026
The company offers a self-learning AI formulation scientist for deployment in a secure environment and AI-generated formulation reports within 24 hours.
The company offers remote access to its robotic formulation lab, where users design experiments in the cloud, the lab executes them, and results stream to a dashboard.
Persist AI designs, builds, and proves custom formulation automation in its Sacramento lab, then deploys it to the client's site with the team trained.
Persist AI offers fee-for-service formulation development with integrated robotic execution and a full-service formulation team. The company says it does not train on client data.
The company will present a poster on its Automated Platform for IVR testing of LAI Microsphere Formulations at the upcoming Controlled Release Society conference.
Persist AI announced its $12M Series A.
Deep dives into formulation science, drug delivery, and the technology powering modern pharma.
The company screened 100+ PLGA microspheres with scientists using a robotic lab and machine-learning models, finding very few conditions that maintain antibody integrity and release behavior.
Insights from the frontlines of formulation — where AI, robotics, and pharmaceutical science come together to accelerate better therapies.
The two companies intend to leverage their complementary expertise and technology to bring a novel long acting injectable and drug product manufacturing platform to market.
Persist AI has successfully raised $4 million in a seed financing round, led by 2048 Ventures with participation from Innospark Ventures, Fellows Fund, Pioneer Fund, Y Combinator, and others.
Persist AI is strengthening its computational modeling and product development capabilities.
Persist AI is accelerating drug development and manufacturing using AI, robotics, and pharmaceutical sciences — so life-saving therapies reach patients faster.
Persist AI combines AI and robotics for high-throughput pharmaceutical formulation development — long-acting injectables, amorphous solid dispersions, parenterals, creams, and in-situ depots.
Persist AI combines AI and robotics for high-throughput pharmaceutical formulation development — long-acting injectables, amorphous solid dispersions, parenterals, creams, and in-situ depots.
How Persist AI uses cookies and similar tracking technologies on this website.
The data protection terms governing how Persist AI processes personal data on behalf of customers.
The page describes how Persist AI collects, uses, and protects personal information.
The page describes how Persist AI collects, uses, and protects personal information.
